Jean Hamilton

All publications

Journal articles

• Woods B, Kearns B, Schmitt L, Jankovic D, Rothery C, Harnan S, Hamilton J, Scope A, Ren S, Bojke L , Wilcox M et al (2024) Assessing the value of new antimicrobials: evaluations of cefiderocol and ceftazidime-avibactam to inform delinked payments by the NHS in England. Applied Health Economics and Health Policy. View this article in WRRO
• Davis S, Pandor A, Sampson F, Hamilton J, Nelson-Piercy C, Hunt BJ, Daru J & Goodacre S (2024) Estimating the value of future research into thromboprophylaxis for women during pregnancy and after delivery: a value of information analysis. Journal of Thrombosis and Haemostasis. View this article in WRRO
• Pandor A, Daru J, Hunt BJ, Rooney G, Hamilton J, Clowes M, Goodacre S, Nelson-Piercy C & Davis S (2022) Risk assessment models for venous thromboembolism in pregnancy and in the puerperium: a systematic review. BMJ Open, 12(10), e065892-e065892. View this article in WRRO
• Kearns B, Cooper K, Orr M, Essat M, Hamilton J & Cantrell A (2022) The incidence and costs of adverse events associated with antidepressants : results from a systematic review, network meta-analysis and multi-country economic model. Neuropsychiatric Disease and Treatment, 18, 1133-1143.
• Rafia R, Martyn-St James M, Harnan S, Metry A, Hamilton J & Wailoo A (2022) A cost-effectiveness analysis of remdesivir for the treatment of hospitalised patients with COVID-19 in England and Wales. Value in Health. View this article in WRRO
• Leaviss J, Davis S, Ren S, Hamilton J, Scope A, Booth A, Sutton A, Parry G, Buszewicz M, Moss-Morris R & White P (2020) Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation. Health Technology Assessment, 24(46), 1-490. View this article in WRRO
• Davis S, Simpson E, Hamilton J, James MM-S, Rawdin A, Wong R, Goka E, Gittoes N & Selby P (2020) Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation. Health Technology Assessment, 24(29). View this article in WRRO
• Simpson E, Martyn-St James M, Hamilton J, Wong R, Gittoes N, Selby P & Davis S (2020) Clinical effectiveness of denosumab, raloxifene, romosozumab, and teriparatide for the prevention of osteoporotic fragility fractures : a systematic review and network meta-analysis. Bone, 130. View this article in WRRO
• Reale S, Hamilton J, Akparibo R, Hetherington M, Cecil J & Caton S (2019) The effect of food type on the portion size effect in children aged 2- 12 years: A systematic review and meta-analysis. Appetite, 137, 47-61. View this article in WRRO
• Tappenden P, Carroll C, Hamilton J, Kaltenthaler E, Wong R, Wadsley J, Moss L & Balasubramanian S (2019) Cabozantinib and vandetanib for unresectable locally advanced or metastatic medullary thyroid cancer: a systematic review and economic model. Health Technology Assessment, 23(8), 1-144. View this article in WRRO
• Squires H, Bermejo I, Poku EN, Cooper K, Stevens J, Hamilton J, Wong R, Denniston AK, Pearce I & Quhill FM (2019) Dexamethasone implant for non-infectious uveitis: is it cost-effective?. British Journal of Ophthalmology. View this article in WRRO
• Bermejo I, Squires H, Poku EN, Cooper K, Stevens JW, Hamilton J, Wong R, Pearce I, Quhill FM & Denniston AK (2019) Adalimumab for non-infectious uveitis: is it cost-effective?. British Journal of Ophthalmology. View this article in WRRO
• Archer R, Hock E, Hamilton J, Stevens J, Essat M, Poku E, Clowes M, Pandor A & Stevenson M (2018) Assessing prognosis and prediction of treatment response in early rheumatoid arthritis: systematic reviews.. Health Technology Assessment, 22(66), 1-294. View this article in WRRO
• Davis S, Rafia R, Carroll C, Hamilton J & Essat M (2018) Pirfenidone for Treating Idiopathic Pulmonary Fibrosis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.. Pharmacoeconomics. View this article in WRRO
• Tappenden P, Simpson E, Hamilton J, Pollard D, Clowes M, Kaltenthaler E, Meiklejohn D & Morley N (2018) Ibrutinib for Treating Relapsed or Refractory Mantle Cell Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics. View this article in WRRO
• Stevenson M, Pandor A, Hamilton J, Stevens J, Rowntree C, Martyn-St James M, Rawdin A & Wong R (2018) Ponatinib for Treating Acute Lymphoblastic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics, 36(7), 759-768. View this article in WRRO
• Pandor A, Stevenson M, Stevens J, James MM-S, Hamilton J, Byrne J, Rudin C, Rawdin A & Wong R (2018) Ponatinib for Treating Chronic Myeloid Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics, 36(8), 903-915. View this article in WRRO
• Phang Romero Casas C, Martyn-St James M, Hamilton J, Marinho DS, Castro R & Harnan S (2018) Rapid diagnostic test for antenatal syphilis screening in low-income and middle-income countries: a systematic review and meta-analysis. BMJ Open, 8(2), e018132-e018132. View this article in WRRO
• Squires HY, Poku E, Bermejo I, Cooper K, Stevens J, Hamilton J, Wong R, Denniston A, Pearce I & Quhill F (2017) A systematic review and economic evaluation of adalimumab and dexamethasone for treating non-infectious intermediate, posterior or panuveitis in adults. Health technology assessment, 21(68). View this article in WRRO
• Bermejo I, Stevenson M, Cooper K, Harnan S, Hamilton J, Clowes M, Carroll C, Harrison T & Saha S (2017) Mepolizumab for Treating Severe Eosinophilic Asthma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics. View this article in WRRO
• Carroll C, Tappenden P, Rafia R, Hamilton J, Chambers D, Clowes M, Durrington P, Qureshi N & Wierzbicki AS (2017) Evolocumab for Treating Primary Hypercholesterolaemia and Mixed Dyslipidaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics, 35(5), 537-547. View this article in WRRO
• Sadler S, Angus C, Gavens L, Gillespie D, Holmes J, Hamilton J, Brennan A & Meier P (2017) Understanding the alcohol harm paradox: an analysis of sex- and condition-specific hospital admissions by socioeconomic group for alcohol-associated conditions in England.. Addiction, 112(5), 808-817. View this article in WRRO
• Hamilton J, Nunes MA, Knight MI & Fryzlewicz P (2017) Complex-valued wavelet lifting and applications. Technometrics, 0-0. View this article in WRRO
• Kearns B, Pandor A, Stevenson M, Hamilton J, Chambers D, Clowes M, Graham J & Kumar MS (2016) Cabazitaxel for Hormone-Relapsed Metastatic Prostate Cancer Previously Treated With a Docetaxel-Containing Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics, 35(4), 415-424. View this article in WRRO
• Davis S, Martyn-St James M, Sanderson J, Stevens J, Goka E, Rawdin A, Sadler S, Wong R, Campbell F, Stevenson M , Strong M et al (2016) A systematic review and economic evaluation of bisphosphonates for the prevention of fragility fractures. Health Technology Assessment, 20(78), 1-406. View this article in WRRO
• Lash GE, Bulmer JN, Li TC, Innes BA, Mariee N, Patel G, Sanderson J, Quenby S & Laird SM (2016) Standardisation of uterine natural killer (uNK) cell measurements in the endometrium of women with recurrent reproductive failure. Journal of Reproductive Immunology, 116, 50-59. View this article in WRRO
• Sanderson J, Martyn-St James M, Stevens J, Goka E, Wong R, Campbell F, Selby P, Gittoes N & Davis S (2016) Clinical effectiveness of bisphosphonates for the prevention of fragility fractures: A systematic review and network meta-analysis. Bone, 89, 52-58. View this article in WRRO
• Stevenson M, Pandor A, Martyn-St James M, Rafia R, Uttley L, Stevens J, Sanderson J, Wong R, Perkins GD, McMullan R & Dark P (2016) Sepsis: the LightCycler SeptiFast Test MGRADE®, SepsiTest™ and IRIDICA BAC BSI assay for rapidly identifying bloodstream bacteria and fungi - a systematic review and economic evaluation.. Health Technology Assessment, 20(46), 1-246. View this article in WRRO
• Carroll C, Tappenden P, Rafia R, Hamilton J, Chambers D, Clowes M, Durrington P, Qureshi N & Wierzbicki AS (2016) Evolocumab for Treating Primary Hypercholesterolaemia and Mixed Dyslipidaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics, 35(5), 537-547.
• Sanderson J, Sudoyo H, Karafet TM, Hammer MF & Cox MP (2015) Reconstructing Past Admixture Processes from Local Genomic Ancestry Using Wavelet Transformation. Genetics, 200(2), 469-481. View this article in WRRO
• Sanderson J, Thompson SG, White IR, Aspelund T & Pennells L (2013) Derivation and assessment of risk prediction models using case-cohort data. BMC Medical Research Methodology, 13(1). View this article in WRRO
• Anchala R, Pinto MP, Shroufi A, Chowdhury R, Sanderson J, Johnson L, Blanco P, Prabhakaran D & Franco OH (2012) The role of Decision Support System (DSS) in prevention of cardiovascular disease: a systematic review and meta-analysis.. PloS one, 7(10), e47064. View this article in WRRO
• Buitrago-Lopez A, Sanderson J, Johnson L, Warnakula S, Wood A, Di Angelantonio E & Franco OH (2011) Chocolate consumption and cardiometabolic disorders: systematic review and meta-analysis. BMJ, 343(aug26 1), d4488-d4488.
• Sanderson J, Fryzlewicz P & Jones MW (2010) Estimating linear dependence between nonstationary time series using the locally stationary wavelet model. Biometrika, 97(2), 435-446.
• Harnan S, Hamilton J, Simpson E, Clowes M, Navega Biz A, Whyte S, Ren S, Cooper K, Abulafi M, Ball A , Beton S et al () Faecal immunochemical tests for patients with symptoms suggestive of colorectal cancer: an updated systematic review and multiple-threshold meta-analysis of diagnostic test accuracy studies. Colorectal Disease. View this article in WRRO
• Harnan S, Kearns B, Scope A, Schmitt L, Jankovic D, Hamilton J, Srivastava T, Hill H, Ku CC, Ren S , Rothery C et al () Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model. Health Technology Assessment, 1-230.
• Woods B, Schmitt L, Jankovic D, Kearns B, Scope A, Ren S, Srivastava T, Ku CC, Hamilton J, Rothery C , Bojke L et al () Cefiderocol for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model. Health Technology Assessment, 1-238.
• Davis S, Pandor A, Sampson F, Hamilton J, Nelson-Piercy C, Beverley H, Jahnavi D, Goodacre S, Carser R, Rooney G & Clowes M () Thromboprophylaxis during pregnancy and the puerperium: a systematic review and economic evaluation to estimate the value of future research. Health Technology Assessment.
• Davis S, Martyn-St James M, Sanderson J, Stevens J, Goka E, Rawdin A, Sadler S, Wong R, Campbell F, Stevenson M , Strong M et al () Corrigendum: A systematic review and economic evaluation of bisphosphonates for the prevention of fragility fractures. Health Technology Assessment, 20(78), 407-424. View this article in WRRO

Conference proceedings papers

• Clough H, Sanderson J, Brown P, Miller A & Cook AJC () ZAP: The role of routine surveillance data in understanding the geography and timing of Salmonella on UK pig farms.. International Conference on the Epidemiology and Control of Biological, Chemical and Physical Hazards in Pigs and Pork

Reports

• Harnan S, Kearns B, Scope A, Schmitt1 L, Jankovic1 D, Hamilton J, Wong R, Srivastava T, Hill H, Chang Ku C , Ren K et al (2021) Final report for the technology evaluation of ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections.
• Salway S, Booth A, Such E, Hamilton J, Powell K, Preston L, Victor C & Raghavan R (2020) How can loneliness and social isolation be reduced among migrant and minority ethnic people? Systematic, participatory review of programme theories, system processes and outcomes

Posters

• Kearns B, Cooper K, Orr M, Essat M, Hamilton J & Cantrell A (2022) POSB7 Adverse Events Associated with Antidepressants: A Systematic Literature Review and Network Meta-Analysis.
• Archer R, Clowes M, Hamilton J, Pandor A, Stevenson MD, Stevens JW, Hock ES & Essat M (2018) Addressing challenges in the conduct of a systematic review of clinical prediction models in rheumatoid arthritis. 25th Cochrane Colloquium, Edingurgh.
• Hamilton J, Archer R, Stevens J, Stevenson M, Hock E, Clowes M, Essat M, Poku E & Pandor A (2018) Clinical prediction models for patients with early rheumatoid arthritis: A systematic review and evidence synthesis. MEMTAM (Methods for Evaluation of medical prediction Models, Test And Biomarkers), Utecht, The Nethe.
• Sanderson J, James MM-S, Davies S, Stevens J, Goka E & Sadler S Clinical effectiveness of bisphosphonates for prevention of fragility fractures: a systematic review and network meta-analysis.